A guide explaining how to perform every Fatality in Mortal Kombat 1 with videos showing what they look like in action and ...

The path to unlocking the secret Floyd battle and Fields stage in Mortal Kombat 1 has become much clearer thanks to TheThiny ...

Mortal Kombat 1's final Khaos Reigns fighter is Terminator 2's T-1000, and though no concrete release date has been given, ...

The latest addition to the series' lineup of ninjas has come in the form of Mortal Kombat 1's Floyd, but he's not necessarily as original as he seems.

Takeda has named Julie Kim as its next CEO. She will replace Christophe Weber who plans to step down in June of 2026 after leading Japan’s largest drugmaker for 11 years. The company called the ...

Julie Kim is set to replace Christophe Weber as the new CEO of Takeda Pharmaceutical, becoming the first woman to lead the more than 240-year-old Japanese drugmaker. Kim, 54, has been running ...

Takeda Pharmaceutical 45020.69%increase; green up pointing triangle named Julie Kim, who heads its U.S. business, as its new chief executive starting in 2026, elevating her to the small but ...

Takeda Canada Inc. (Takeda ... to its list of plasma products distributed in Quebec.1 The treatment will now be reimbursed for adult and pediatric patients two years of age and older starting ...

The proposed merger of the two Cambridge drugmakers is off, but Sage says it's open to "strategic alternatives" — including a sale. Sage Therapeutics Inc. is looking for a deal — but it’s ...

The Boston biotech has raised a $97 million Series B investment to support its upcoming Phase 1 clinical trials for KCNT1-related epilepsy and Huntington’s disease. Atalanta’s pipeline is ...

Evox Therapeutics is the second UK biotech to sign a big deal with a pharma giant this week, snaring an $882 million partnership with Takeda for up ... it also won a £1.5 million ($1.8 million ...